Neurological Clinic, Ospedale dell´Angelo, Venezia Mestre, Italy REVIEW RETURNED 09-Jan-2018
GENERAL COMMENTS
Nice study, with adequate sample size and well conducted. I only have some questions to the authors: -what is the origin of arterial stenosis if it´s not atherosclerotic? Vasculitis? Dissection? Could you clarify this point in the manuscript? If all your stenosis are atherosclerotic related I suggest to change the term "Arterial stenosis (AS)" with "Arterial Atherosclerosis" -have you also studied internal carotid artery and vertebral artery in their distal tracts? -which was the antithrombotic therapy of these patients? -do you started a therapy to reduce uric acid concentration? do you have follow up data on these patients? -please rewrite the Abstract, is a little bit messy...
REVIEWER

Kye Hun Kim
Chonnam National University Hospital, Korea, Republic of REVIEW RETURNED 21-Jan-2018
GENERAL COMMENTS Manuscript ID: bmjopen-2017-020681
Title: Relation of serum uric acid to asymptomatic proximal extracranial artery stenosis in a middle-aged Chinese population
The authors performed laboratory and ultrasound examination of extracranial arteries in petrochemical employees and analysed them to reach a conclusion that higher serum uric acid (SUA) levels might predict arterial stenosis, especially in the vertebral arteries. Although there have been controversies in association between SUA and atherosclerotic cardiovascular diseases (ASCVD), SUA itself is closely associated in many aspects of metabolic syndrome, chronic kidney disease, etc., and cannot be easily neglected in ASCVD. The present study has its value on demonstrating possible relation between SUA and vertebral arterial stenosis, but there are many important questions which should be pointed out.
Comments;
1. As the authors mentioned, population in the higher quartiles of serum uric acid tended to be hypertensive, more obese 5. The present study has lots of limitations because of retrospective nature. Please introduce the study limitations of this study.
VERSION 1 -AUTHOR RESPONSE
Response to the reviewer's comments: Reviewer 1 Comment 1: Page 9, line 9 The basis for setting >30% as the significant stenosis rate for vertebral artery origin -V2 segment is unclear. If the evaluation of stenosis rate in vertebral arteries was in conformance with the method used in NASCET, it is necessary to state the specific calculation procedure. Response: Thank you for your worthy suggestion. We stated the calculation procedure in the methods section of the revised manuscript (Page 9, Lines 3-5).
Comment 2: Page 13, line 11
In the association between uric acid level and extracranial major artery stenosis, was there a reason for the dissociation between the common carotid artery and vertebral arteries? Differences between extracranial artery stenosis locations would be related to differences in vascular risk factors and vascular sensitivity so it is necessary to discuss the pathophysiology of this in a little more detail.
Response: Thank you! The differences between extracranial artery stenosis locations could be related to differences in vascular risk factors and vascular sensitivity. Vertebral artery is much smaller (diameter: 3-4mm) and more twisted than CA (diameter: 6-8mm) and I/SA (diameter: 6-10mm), which may contribute to the hemodynamic difference. Previous evidence revealed that increased SUA levels have been associated with oxidative stress, and endothelial dysfunction, which may further increase the risk of vascular stenosis. We hypothesize the more the narrow the arteries, the more the risk of stenosis. We included these possible reasons of differences between extracranial artery stenosis locations in the discussion section of revised manuscript (Page 13, Lines 16-22 and Page 14, Lines 1-2).
Comment 3: Page 10, line 9 Why was eGFR added to age and gender in the adjustment factors for model 1? As an element of age is taken into account in eGFR, wouldn't age and gender alone be sufficient? Response: Thank you! We included a model adjusted for age and gender only in table 1.
Comment 4:
Introduction is too long and redundant, you should revise it a little more briefly. Response: Thank you for your suggestion. We revised the introduction part of the manuscript to meet the reviewer's comment.
Reviewer 2 Comment 1: What is the origin of arterial stenosis if it´s not atherosclerotic? Vasculitis? Dissection? Could you clarify this point in the manuscript? If all your stenosis are atherosclerotic related I suggest to change the term "Arterial stenosis (AS)" with "Arterial Atherosclerosis" Response: Thank you for the remark. The present study does not provide data on the underlying cause of the stenosis, which makes it difficult to categorize the origin of arterial stenosis. Only 67.7% of the population had dyslipidemia, thus, the data do not provide sufficient information to consider all stenosis were related to Atherosclerosis. Therefore, we would like to maintain the term arterial stenosis. However, we are considering the reviewer's point in the limitation section (Page 16, Lines 6-7).
Comment 2: Have you also studied internal carotid artery and vertebral artery in their distal tracts? Response: Our data didn't include the internal carotid artery and vertebral artery in their distal tracts. We appreciate the reviewer's view.
Comment 3: which was the antithrombotic therapy of these patients?
Response: Thank you! This study was conducted in asymptomatic community participants. Therefore, the study doesn't include data on antithrombotic therapy.
Comment 4: do you start a therapy to reduce uric acid concentration? Do you have follow up data on these patients? Response: Thank you! As researchers, we recommended appropriate measures to be taken to reduce the elevation of SUA, following the results of this study. Also, follow up data was beyond the scope of this study.
Comment 5: Please rewrite the Abstract, is a little bit messy... Response: Thank you for your correction, we rewrote the abstract to improve its content and organization.
Reviewer 3 Comment 1: As the authors mentioned, population in the higher quartiles of serum uric acid tended to be hypertensive, more obese (reflected by higher BMI), have lower eGFR, and higher prevalence of hypertension and dyslipidaemia. Those findings can be major confounding factors of the results, and in the table 3, we can see that predictive power of SUA for arterial, CCA, VA, I/SA stenosis is markedly attenuated when you performed adjustment for multiple possible confounding factors (model 3). Considering that SUA is closely associated with many aspects of metabolic syndrome, results of adjustment for multiple possible confounding factors hold important meanings. How could the authors conclude that SUA has independent association with proximal extracranial arterial stenosis, despite results of model 3? Please discuss these issues in the discussion. Response: Thank you for the remark. We have addressed the potential impact of the major confounding factors for model 3 in the discussion section of the manuscript. We agree with the reviewer that SUA is closely associated with hyperlipidemia and various aspects of metabolic syndrome. The multivariable adjustment attenuated the estimates. Inter-relationships between variables, even if not approaching high collinearity, can have a substantial impact on regression model results, therefore, it is difficult to separate out the independent contribution of SUA in PEAS. Despite the multiple possible confounding factors, the result of model 3 confirmed that participants in the highest quartile of SUA levels had increased risk of PEAS, even after adjustment for the traditional risk factors for CVD, including statin use and dyslipidemia. Thus we corrected the statement in the discussion section stated as "SUA levels independently associated with the risk of PEAS" to "elevated SUA levels associated with PEAS", and we accompanied with a recommendation for further study to address the need for confirmatory evidence in order to prove the independent association of SUA level with risk of PEAS. The recommendation read as "Considering that SUA is closely associated with many aspects of metabolic syndrome, a nested case-control study is required to confirm the association between elevated SUA and the risk of PEAS", is included in the discussion section of the revised manuscript.
Comment 2: In all arteries, Risk of vascular stenosis is low in Q3 than in Q2, when you used model 3. How can the authors explain this phenomenon? Response: Brilliant! Risk of vascular stenosis in Q3 was lower than Q2. We revised the data, and the analysis replicated the same results, showing that there is no error in the data analysis. However, this may be explained by (1) the multicollinearity between BMI, Hypertension, and SUA; (2) difference in predictive power of SUA and other confounding variables for the risk of PEAS. For instance, (a) lipid profile (LDL, glycerol, and total cholesterol) may have higher predictive power for the risk of PEAS compared with SUA; (b) The combined effect of extremely high level of SUA and an increased proportion of dyslipidemia might increase the risk of PEAS. In our study, the predictive power of SUA was greatly attenuated in model 3, which included BMI, hypertension,and dyslipidemia. This finding suggests that there is inter-relationship between high levels of SUA and atherosclerosis, since the use of model 3, which included BMI, hypertension, and dyslipidemia, greatly attenuated the predictive power of SUA on vascular stenosis, than when we used model 1 or 2.
Comment 3: According to the authors' results, the vertebral arteries seem to be most influenced by SUA, than the CCA, or I/SAs are. What do authors think of the underlying mechanism of different effects of SUA to each artery? Please discuss this issue also in the discussion. Response: Thank you! Please kindly have a look at the response for comment 2 from reviewer 1. We included the underlying mechanism of different effects of SUA to each artery in the discussion section of revised manuscript (Page 13, Lines 16-22 and Page 14, Lines 1-2).
Comment 4: Dyslipidaemia is a major risk factor of atherosclerosis, and statin and LDL-lowering have been showing invaluable benefits in controlling atherosclerosis and prevention of further ASCVD. In the authors' data, 67.7% of the population seems to have dyslipidaemia, but only 2.1% are on statin use. This finding may hold a very important message, since use of model 3, which included statin use and dyslipidaemia, greatly attenuated the predictive power of SUA on vascular stenosis, than when the authors used model 1 or 2. The authors should clarify the reason, and potential confounding effect of 'undertreated dyslipidaemia' should be pointed out. If many subjects of dyslipidaemia are not indicated for statin treatment according to the current guidelines, the authors should state detailed features, such as distribution of LDL levels.
Response: Thank you very much! We included the possible confounding effect of dyslipidemia in the discussion section of revised manuscript. Regarding the low rate of statin use could be due to the nature of our study design. We included only asymptomatic middle age population from the community. Therefore, lack of regular physical examination/ medical check-up and poor health care seeking behavior can be mentioned.
Comment 5: The present study has lots of limitations because of retrospective nature. Please introduce the study limitations of this study. Response: Thank you for the remark. We have extended the possible limitations of the present study as per the reviewer's recommendation.
VERSION 2 -REVIEW REVIEWER
Toshitaka Umemura Chubu Rosai Hospital, Japan REVIEW RETURNED 01-Apr-2018
GENERAL COMMENTS
The manuscript has been improved and the response of the authors to my concerns or suggestions is satisfactory.
REVIEWER
Kye Hun Kim
Chonnam National University Hospital, Korea REVIEW RETURNED 27-Mar-2018
GENERAL COMMENTS
The authors addressed the raised issues form the reviewer appropriately. Thanks
REVIEWER
Filippo Farina
Neurology Department "Ospedale dell'Angelo" Clinic, MestreVenezia, Italy REVIEW RETURNED 04-Apr-2018
GENERAL COMMENTS
The manuscript has been improved from previous version, but I still have some major points that must be clarified: 1) how did you diagnose and grade the CCA and VA stenosis? You didn't cite any velocity flow threshold or ultrasonographic criteria in your methods. I think this part needs to be expanded. 2) you wrote that "The previous studies defined stenosis as ≥75%, while the current study defined stenosis as ≥30%". Is this referred to CCA or VA or both? Since it's almost impossible to clearly visualize a plaque with B mode in the VA, how did you measure the grade of stenosis of a non hemodynamically relevant plaque in the VA? 3) Since you are not sure about the nature of the stenosis you can not state in the discussion that SUA levels are related to atherosclerosis at all. Please correct!
VERSION 2 -AUTHOR RESPONSE
Reviewers' Comments to Author: Reviewer: 2 The manuscript has been improved from previous version, but I still have some major points that must be clarified: 1. How did you diagnose and grade the CCA and VA stenosis? You didn't cite any velocity flow threshold or ultrasonographic criteria in your methods. I think this part needs to be expanded. Response: Thank you! We included the velocity flow threshold criteria in our methods. The diameter measurements were obtained based on the North American Symptomatic Carotid Endarterectomy Trial (NASCET) method. Regarding the grading of the 50% CCA and VA stenosis, we used a previously validated CT angiography-derived duplex ultrasound velocity criteria.
2. You wrote that "The previous studies defined stenosis as ≥75%, while the current study defined stenosis as ≥30%". Is this referred to CCA or VA or both? Since it's almost impossible to clearly visualize a plaque with B mode in the VA, how did you measure the grade of stenosis of a non hemodynamically relevant plaque in the VA? Response: Thank you very much for the worthy comment. We found out there was miscommunication between the reviewers and authors as the figure written ≥30% was supposed to be reported as ≥50%. We appreciate the reviewer for rising this important point that helped us to review the data, discuss with the radiologists who were responsible for conducting the duplex ultrasound and revise the reporting. The 50% stenosis definition applied for both CCA and VA.
3. Since you are not sure about the nature of the stenosis you can not state in the discussion that SUA levels are related to atherosclerosis at all. Please correct! Response: Thank you for your remark! We considered your worthy suggestion. The following sentences in paragraph 5 in the discussion section by read as "The present study not only substantiated previous findings on the impact of SUA on atherosclerosis burden, but we also linked elevated SUA and asymptomatic PEAS." is replaced by "The present study linked elevated SUA and asymptomatic PEAS. 
